SNOA
Sonoma Pharmaceuticals, Inc.
+0.02 (+1.99%)1.25USD4.4K成交股數6.0M市值–本益比(近四季)0.3股價營收比+59.5%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 6.4M+60% | 5.6M+56% | 4.3M+22% | 5.6M+65% | 4.0M+17% | 3.6M+14% | 3.6M+31% | 3.4M-1% | 3.4M | 3.1M | 2.7M | 3.4M |
| 營業成本 | 3.8M | 3.4M | 2.7M | 3.5M | 2.6M | 2.3M | 2.2M | 2.1M | 2.3M | 1.7M | 1.7M | 2.2M |
| 毛利 | 2.6M+76% | 2.2M+72% | 1.7M+21% | 2.1M+62% | 1.5M+34% | 1.3M-13% | 1.4M+37% | 1.3M+8% | 1.1M | 1.5M | 990K | 1.2M |
| 毛利率 | 40.2% | 39.2% | 37.9% | 37.8% | 36.5% | 35.6% | 38.0% | 38.5% | 31.7% | 46.5% | 36.3% | 35.1% |
| 研發費用 | 597K | 545K | 557K | 575K | 594K | 427K | 506K | 470K | 409K | 601K | 536K | 325K |
| 銷售管理費用 | 2.0M | 2.0M | 1.8M | 1.9M | 2.0M | 1.9M | 1.7M | 2.0M | 2.1M | 1.7M | 1.7M | 2.1M |
| 營業利益 | −40K-96% | −351K-66% | −678K-20% | −337K-71% | −1.1M-22% | −1.0M+22% | −850K-30% | −1.2M-5% | −1.4M | −844K | −1.2M | −1.2M |
| 營業利益率 | -0.6% | -6.3% | -15.6% | -6.0% | -27.3% | -28.9% | -23.7% | -34.6% | -41.0% | -26.9% | -44.2% | -36.2% |
| 稅後淨利 | −330K-73% | 2.6M-380% | −819K+34% | −534K-53% | −1.2M-133% | −928K+7% | −610K-59% | −1.1M-19% | 3.8M | −866K | −1.5M | −1.4M |
| 淨利率 | -5.2% | 46.7% | -18.8% | -9.5% | -30.9% | -26.0% | -17.0% | -33.7% | 109.7% | -27.6% | -54.3% | -41.4% |
| 稀釋 EPS | -0.09-88% | -0.33-48% | -0.48-19% | -0.32-76% | -0.76-75% | -0.63-60% | -0.59-90% | -1.34+362% | -3.00 | -1.59 | -5.75 | -0.29 |
| 稀釋股數 | 3.8M | 1.7M | 1.7M | 1.6M | 1.6M | 1.5M | 1.0M | 851K | 455K | 546K | 258K | 4.9M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.3M | 2.4M | 2.6M | 3.0M | 3.6M | 5.2M | 4.1M | 2.6M | 3.1M | 2.4M | 2.1M | 3.5M |
| 應收帳款 | 3.2M | 2.5M | 2.4M | 2.7M | 2.6M | 2.4M | 3.2M | 3.2M | 2.9M | 2.9M | 2.2M | 2.4M |
| 存貨 | 3.8M | 3.7M | 3.7M | 3.6M | 3.8M | 3.1M | 2.8M | 2.7M | 2.7M | 3.0M | 2.5M | 2.7M |
| 總資產 | 18.1M | 14.0M | 13.6M | 13.9M | 14.6M | 13.7M | 13.7M | 13.7M | 14.7M | 14.6M | 13.6M | 15.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 11.5M | 10.9M | 10.2M | 10.1M | 10.5M | 8.8M | 8.3M | 8.7M | 8.6M | 7.9M | 8.0M | 8.7M |
| 股東權益 | 6.6M | 3.1M | 3.4M | 3.8M | 4.1M | 4.9M | 5.4M | 5.0M | 6.1M | 6.7M | 5.7M | 7.2M |
| 負債比 | 63.6% | 77.8% | 74.8% | 72.7% | 72.2% | 64.4% | 60.9% | 63.6% | 58.4% | 54.2% | 58.4% | 54.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −649K-68% | – | – | – | −2.0M | – | – | −912K+324% | – | – | – | −215K |
| 資本支出 | 2K | – | – | – | 106K | – | – | 5K | – | – | – | 17K |
| 自由現金流 | −651K-69% | – | – | – | −2.1M | – | – | −917K+295% | – | – | – | −232K |
| 折舊攤銷 | 32K | – | – | – | 36K | – | – | 39K | – | – | – | 45K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -10.2% | – | – | – | -52.8% | – | – | -27.0% | – | – | – | -6.8% |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 349K
| 服務 | 349K | 100.0% | +211.6% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 19.5M | +36.7% | 3K | 0.0% | -1.89 | −4.1M |
| FY2025 | 14.3M | +12.2% | 3K | 0.0% | -2.79 | −168K |
| FY2024 | 12.7M | -4.0% | 5K | 0.0% | -10.63 | −2.4M |
| FY2023 | 13.3M | +5.1% | −5.2M | -38.8% | -1.52 | −6.4M |
| FY2022 | 12.6M | -32.2% | −5.1M | -40.3% | -1.92 | −4.4M |
| FY2021 | 18.6M | +3.9% | −4.0M | -21.2% | -1.97 | −3.6M |
| FY2020 | 17.9M | -5.5% | −3.3M | -18.5% | -2.24 | −4.8M |
| FY2019 | 19.0M | – | −11.8M | -62.2% | -12.77 | −11.8M |